Email - Women ride 100 miles for Alzheimer's research and awareness

Donate

Enews from the Alzheimer's Association

Having trouble viewing this message? You may view it as a web page. You may also view e-news archives.
To prevent mailbox filters from deleting your Alzheimer's Association email communications, please add alzheimers_enews@alz.org to your address book.

24/7 Helpline: 800.272.3900

Women ride 100 miles for Alzheimer’s research and awareness

Last year, Cathy Harm and her friend Laura rode 100 miles in the Ride to End ALZ®, a cycling event that raises funds and awareness for Alzheimer’s research. Their efforts were in honor of Cathy’s mother, who died from complications of Alzheimer’s, and Laura’s mother, who’s living with the disease. This year, the friends are committed to riding again: “Being part of Ride to End ALZ allows me to take action and to fulfill my personal commitment to do all I can in the fight against this disease,” Cathy says.

Make 2X the impact during our $100,000 Fall Matching Gift Challenge

Any gift you make can be matched, up to $100,000, during this Matching Gift Challenge, and your support can go twice as far to help accelerate research and provide quality care and support to those living with Alzheimer’s. Please make a gift that can double in impact before this incredible opportunity ends on Oct. 15.

Help fight Alzheimer's

Give Now

Get Involved

Your Local Community

Find a chapter here

Collins announces departure from National Institutes of Health

The Alzheimer’s Association and the Alzheimer’s Impact Movement are immensely grateful for Francis S. Collins, M.D., Ph.D., who announced his decision to step down as director of the National Institutes of Health (NIH). During his tenure, Alzheimer’s and dementia research funding at the NIH grew from less than $450 million to $3.2 billion.

More Resources:

Stages of Alzheimer's

Behaviors

Coping Strategies

Care Training


My Preferences:
Unsubscribe To stop receiving our weekly e-newsletter, simply unsubscribe.		Subscribe Was this e-newsletter forwarded to you? Subscribe to get it weekly.